General Information of the Compound
Compound ID
CP0208538
Compound Name
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
    Show/Hide
Synonyms
Dihydroergocristine
Nehydrin
    Show/Hide
Structure
Formula
C35H41N5O5
Molecular Weight
611.743
Canonical SMILES
CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O
    Show/Hide
InChI
InChI=1S/C35H41N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41)/t23-,25-,27-,28+,29+,34-,35+/m1/s1
    Show/Hide
InChIKey
DEQITUUQPICUMR-HJPBWRTMSA-N
CAS
11024-29-6
17479-19-5
26913-93-9
Physicochemical Property
logP
2.7172
Rotatable Bonds
5
Heavy Atom Count
45
Polar Areas
118.21
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
6
Complexity
45

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 107715
SID: 14838672
ChEMBL ID
CHEMBL601773
DrugBank ID
DB13345
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000009 LLC-PK1 Sus scrofa (Pig)  1
1
Ki = 16000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Dihydroergocristine )
Drug Name Dihydroergocristine
Company Sanochemia Pharmazeutika AG
Indication
Alcohol dependence
Approved
Target(s)
Adrenergic receptor alpha-2C (ADRA2C)
Modulator